MarketPeel
Insider Trading Intelligence
Pricing
…
DC

David Colleran

ANIK
EVP, GENERAL COUNSEL, CORP SEC · ANIKA THERAPEUTICS, INC. · CIK 0001646558
FILING MIX · LIFETIME51%/49%
BUYS
30
SELLS
29
TOTAL VALUE
$569.8K
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
67,570
AVG SELL PX
$20.28
TRADE KIND
SHOWING 59 / 59
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David Colleran, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+4.40%+3.34%+1.06%+1.06%—
14d2+100.00%+1.87%+5.42%-3.56%-3.56%—
30d2+0.00%-2.35%+2.95%-5.29%-5.29%—
60d2+50.00%-3.30%-2.55%-0.75%-0.75%—
90d2+50.00%-6.60%-2.30%-4.30%-4.30%—
180d2+50.00%+14.71%-2.10%+16.81%+16.81%—
1y2+100.00%+12.52%+1.09%+11.43%+11.43%—
2y2+50.00%+10.35%+32.24%-21.89%-21.89%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIK · 67,570 shares · as of Mar 15, 2026
017,36634,73252,09769,463202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 30 buys / 29 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
6,449——69,463Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
6,449——6,448Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,893$14.20$26.9K67,570Mar 15, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
4,168$14.20$59.2K63,014Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
9,388——18,777Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
9,388——62,488Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,694——67,182Mar 14, 2026Mar 17, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
5,465——55,019Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
5,465——0Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,919$14.96$28.7K53,100Mar 9, 2026Mar 11, 2026 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,893$15.91$30.1K47,954Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
6,448——12,897Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
6,448——49,847Mar 17, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,669——13,669Mar 14, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,165——28,165Mar 14, 2025Mar 18, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,250$16.79$37.8K43,399Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
7,663——45,649Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
7,663——0Mar 11, 2025Mar 13, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
5,465——39,590Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
5,465——5,465Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,604$16.62$26.7K37,986Mar 10, 2025Mar 11, 2025 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
46,875——46,875Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,345——19,345Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
7,662——7,663Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
5,465——29,188Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,605$25.42$40.8K27,583Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
3,682——24,804Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
7,662——35,245Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
3,682——0Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,250$25.79$58.0K32,995Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,081$25.42$27.5K23,723Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
5,465——10,930Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
7,663——15,325Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
7,663——22,538Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,250$26.10$58.7K20,288Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,081$26.91$29.1K14,875Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
3,683——15,956Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,790——35,790Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,395——16,395Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
3,683——3,682Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
2,500——13,007Mar 4, 2023Mar 7, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,500——0Mar 4, 2023Mar 7, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
734$31.59$23.2K12,273Mar 4, 2023Mar 7, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
1,500$21.37$32.1K9,867May 11, 2022May 12, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
1,500$26.65$40.0K8,367Mar 14, 2022Mar 16, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,864——35,864Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,988——22,988Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
1,081$26.22$28.3K6,867Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
3,682——7,948Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
3,682——7,365Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,500——2,500Mar 4, 2022Mar 7, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
2,500——5,000Mar 4, 2022Mar 7, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
734$31.06$22.8K4,266Mar 4, 2022Mar 7, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,681——27,681Mar 9, 2021Mar 11, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,047——11,047Mar 9, 2021Mar 11, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, General Counsel, Corp Sec
2,500——2,500Mar 4, 2021Mar 8, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, General Counsel, Corp Sec
2,500——5,000Mar 4, 2021Mar 8, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Mar 4, 2020Mar 6, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,500——7,500Mar 4, 2020Mar 6, 2020 ↗View →
Other insiders · ANIK
Loading peer insiders…
About this filer
CIK 0001646558
ROLE
EVP, General Counsel, Corp Sec
PRIMARY
ANIK
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001646558DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback